Andrew C. Flick
Pfizer (United States)(US)Université Bourgogne Franche-Comté(FR)Takeda (United States)(US)
Publications by Year
Research Areas
Cyclopropane Reaction Mechanisms, Asymmetric Synthesis and Catalysis, Chemical synthesis and alkaloids, Chemical Reactions and Isotopes, Synthesis and Biological Evaluation
Most-Cited Works
- → Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S )-2,2-Difluorocyclopropyl)((1 R ,5 S )-3-(2-((1-methyl-1 H -pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)(2018)170 cited
- → Rhodium(II)-Catalyzed Aziridination of Allyl-Substituted Sulfonamides and Carbamates(2004)144 cited
- → Synthetic Approaches to the New Drugs Approved During 2015(2017)136 cited
- → Synthetic approaches to the 2011 new drugs(2013)104 cited
- → Synthetic approaches to the 2014 new drugs(2016)98 cited
- → Synthetic approaches to the 2009 new drugs(2010)83 cited